Survey highlights success criteria for EU drug approval applications
This article was originally published in Scrip
Executive Summary
Those companies most likely to get a new drug approved by the European Medicines Agency (EMA) tend to be larger firms with more resources and more experience in drug development and approval applications, and which have made full use of the scientific advice offered by the agency.